Treatment of aplastic anemia in children with high dose methyl prednisolone.
Indian Pediatr
;
1995 Oct; 32(10): 1061-5
Artículo
en Inglés
| IMSEAR
| ID: sea-9550
ABSTRACT
Severe aplastic anemia (SAA) in children has been previously treated with high dose methyl prednisolone (HDMP) with favorable results. We reviewed our experience with intravenous HDMP. Seven children with a diagnosis of SAA confirmed on bone marrow biopsy were treated with 300 mg/kg total dose of intravenous HDMP over a 4 week period. Patients were closely monitored for response and side effects. HDMP was well tolerated except for hyperglycemia in one case. Six of the seven patients showed no response to HDMP. This observation is in stark contrast with previous trials on use of HDMP in SAA. It is concluded that HDMP should be reserved only for patients with milder bone marrow hypoplasia.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Infusiones Intravenosas
/
Femenino
/
Humanos
/
Masculino
/
Metilprednisolona
/
Niño
/
Preescolar
/
Resultado del Tratamiento
/
Relación Dosis-Respuesta a Droga
/
Anemia Aplásica
Idioma:
Inglés
Revista:
Indian Pediatr
Año:
1995
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS